Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03718962
Other study ID # 20180205R
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 30, 2018
Est. completion date January 30, 2020

Study information

Verified date December 2019
Source Shin Kong Wu Ho-Su Memorial Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Vitiligo is a relatively common acquired disorder of pigmentation characterized by the development of well-defined white macules on the skin. Biopsies of lesional skin reveal a loss of epidermal melanocytes. Lesions may occur in a localized or generalized distribution and may coalesce into large, depigmented areas. Given the contrast between the white areas and normal skin, the disease is most disfiguring in darker skin types and has a profound impact on the quality of life of both children and adults . Patients with vitiligo often experience stigmatization, social isolation, and low self-esteem. The therapys include topical steroids, topical immunosuppresant, systemic steroids, phototherapy, and surgery.

The aim of this study is to investigate the effect of phototherpy and accupuncture combined therapy for vitiligo patients.


Recruitment information / eligibility

Status Completed
Enrollment 9
Est. completion date January 30, 2020
Est. primary completion date January 30, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

Clinical diagnosis of Vitiligo

Exclusion Criteria:

- pregnancy

- immune disorder

- infection

- other dermatosis in treating areas

Study Design


Related Conditions & MeSH terms

  • Brief Description of Focus of Study Instead
  • Vitiligo

Intervention

Device:
Surrounding needling+ phototherapy
Surrounding needling+ phototherapy
phototherapy
phototherapy

Locations

Country Name City State
Taiwan ShinKongHospital Taipei

Sponsors (1)

Lead Sponsor Collaborator
Shin Kong Wu Ho-Su Memorial Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary repigmentation repigmentation amount 12weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05000814 - Study of Cost-effectiveness of the Airway Management in Thoracic Surgery